PPP1R13B-DT and cancer: By analyzing The Cancer Genome Atlas (TCGA) database and in-house samples, we found HITT to be downregulated in multiple types of cancer and decreased HITT expression to be associated with advanced stages of colon, bladder, breast, and liver cancers.